Heron Therapeutics (NasdaqCM:HRTX) Q4 2025 Earnings call February 26, 2026 08:30 AM ET Company ParticipantsCraig Collard - CEOIra Duarte - EVP and CFOKevin Warner - SVP, Medical Affairs, Strategy, and EngagementMark Hensley - COOMelissa Jarel - Executive Director of LegalConference Call ParticipantsBrandon Folkes - Senior Research AnalystCarl Byrnes - Senior Research AnalystSerge Belanger - Senior AnalystOperatorGood day. Thank you for standing by. Welcome to the Heron Therapeutics Q4 2025 conference call. ...